The researchers found beta-blocker use to be a risk factor for hospitalizations for heart failure among these patients with “stiff heart” heart failure.
Kaylee Schwertfeger, PhD, an associate professor in the Department of Laboratory Medicine and Pathology, and Emily (Irey) Jesser, a graduate student, work on a team determined to discover new information leading to better treatments for breast cancer using a non-tumor cell and the body’s immune system.
U of M Medical School researchers Lucie Turcotte, MD, and Joseph Neglia, MD, MPH, conducted a study that looked at childhood cancer survivors treated with different classes of chemotherapy. The goal was to understand on a deeper level how patients were affected if radiation was removed from treatment.
New University of Minnesota Medical School research finds postpartum women are generally getting prescribed more narcotics than they need. Cresta Jones, MD, FACOG believes establishing new guidelines will help protect patients.
An interdisciplinary team of researchers and providers from the University of Minnesota and M Health Fairview hope their studies will lead to a new medical tool that dramatically improves care for movement-limited patients.
Melissa Geller, MD, MS, and David Masopust, PhD, were the 2019 Distinguished Lectureship Award honorees on Nov. 14 at the Dean’s Distinguished Research and Lectureship.
Nearly 3 million Americans are living with Atrial fibrillation (AFib), which is an arrhythmia that can lead to blood clots, stroke, heart failure and other complications.
New research suggests that during decision-making, neurons in the brain are capable of much more complex processing than previously thought.
The survey found that patients who were assigned VALUE students were more than twice as likely to rate their care as “excellent.”
Mark Thomas, PhD, neuroscientist and scientific director for the U of M Medical Discovery Team (MDT) on Addiction, believes researchers have an obligation to talk with the public about the societal challenges of addiction.